Dark Forest Capital Management LP Bristol Myers Squibb CO Transaction History

Dark Forest Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $512,674 - $569,244	8,047 Added 879.45%	8,962 $573,000
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $27,663 - $31,377	421 Added 85.22%	915 $63,000
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $33,829 - $40,058	494 New	494 $35,000
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $68,163 - $79,462	-1,271 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $75,205 - $88,093	1,271 New	1,271 $75,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.